Jun 15, 2023 · Abemaciclib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer ...
People also ask
Is abemaciclib a chemotherapy drug?
What kind of therapy is abemaciclib?
How many years do you have to take abemaciclib?
Is Verzenio a form of chemotherapy?
Abemaciclib
Medication
>
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6. Wikipedia
Verzenio (abemaciclib) is a treatment for both HR+, HER2-, high risk, node positive early breast cancer and for certain types of HR+, HER2- metastatic ...
Apr 8, 2024 · Abemaciclib is a type of targeted cancer drug. It is a treatment for breast cancer. Find out about how you have it, possible side effects ...
Abemaciclib is used together with tamoxifen or an aromatase inhibitor (eg, anastrozole, exemestane, letrozole) to treat hormone receptor (HR)-positive, HER-2 ...
Oct 3, 2017 · FDA label information for this drug is available at DailyMed. Use in Cancer. Abemaciclib is approved to treat: Breast cancer ...
Abemaciclib is a targeted or biological therapy drug. When used to treat breast cancer, abemaciclib is taken alongside hormone (endocrine) therapy.
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers.
Abemaciclib is a medication used to treat HR+ HER2- advanced or metastatic breast cancer. Brand Names. Verzenio. Generic Name: Abemaciclib; DrugBank Accession ...
Mar 3, 2023 · The recommended abemaciclib starting dose is 150 mg taken twice daily with tamoxifen or an aromatase inhibitor until completion of 2 years of ...
Abemaciclib represents the first selective inhibitor of CDK4 and CDK6 with a safety profile allowing continuous dosing to achieve sustained target ...
Visit the website to view 5 year data and helpful resources for your patients. Visit the website to find helpful resources for your patients.